Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析

【英語タイトル】Centers for Disease Control and Prevention - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA8011492)・商品コード:DATA8011492
・発行会社(調査会社):GlobalData
・発行日:2017年12月22日
・ページ数:31
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities from expensive and dangerous health threats. It offers services in the areas of attention-deficit hyperactivity disorder, cancer, diabetes, heart disease, flu, and sexually transmitted diseases. CDC also offers laboratory safety services by conducting scientific research. The institute has collaboration with schools and universities, business, labor, public health associations, industries, international health organizations and others to prevent human health. CDC is headquartered in Atlanta, Georgia, the US.

Centers for Disease Control and Prevention – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centers for Disease Control and Prevention, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Centers for Disease Control and Prevention, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Centers for Disease Control and Prevention, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Centers for Disease Control and Prevention, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Centers for Disease Control and Prevention, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Centers for Disease Control and Prevention, Medical Equipment, Deal Details 10
Partnerships 10
Centers for Disease Control and Prevention Enters into Research Agreement with Edico Genome 10
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 11
Bruker Enters Into Research Agreement With Special Bacteriology Reference Laboratory 12
Centers for Disease Control and Prevention – Key Competitors 13
Centers for Disease Control and Prevention – Key Employees 14
Centers for Disease Control and Prevention – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Legal and Regulatory 16
Jan 04, 2017: New Antimicrobial Stewardship Standard issued for US hospitals to fight antimicrobial resistance 16
Government and Public Interest 17
May 05, 2017: CDC updates guidance on interpretation of Zika testing results for pregnant women 17
Nov 29, 2016: Open-heart surgery patients notified of potential infection risk 18
Product News 19
Dec 05, 2017: Screening for Critical Congenital Heart Disease at Birth Saves Lives 19
Jul 19, 2016: New system uses electrical conductivity to measure dry blood samples used in infant HIV screening, testing for metabolic disorders 20
Jun 22, 2016: U.S. healthcare facilities have capacity to meet colorectal cancer screening goals 21
May 18, 2016: CDC expanding groundbreaking disease identification tool 22
May 05, 2016: The Parkview Mirro Center for Research and Innovation Initiates Study to Demonstrate Value of Personalized Patient Engagement for Those Suffering from Heart Failure 23
Apr 14, 2016: Increased use of type of diagnostic test poses challenge to tracking of foodborne illness 24
02/26/2016: New CDC Laboratory Test for Zika Virus Authorized for Emergency Use by FDA 26
Product Approvals 27
Feb 26, 2016: New CDC Laboratory Test for Zika Virus Authorized for Emergency Use by FDA 27
Other Significant Developments 28
Oct 09, 2017: N.J. Perinatal Collaborative Receives CDC Grant 28
Mar 09, 2017: NTT DATA Awarded Contract by the Centers for Disease Control and Prevention 29
Apr 28, 2016: ICF International awarded $14 million in task orders by Centers for Disease Control and Prevention 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Centers for Disease Control and Prevention, Medical Equipment, Key Facts 2
Centers for Disease Control and Prevention, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Centers for Disease Control and Prevention, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Centers for Disease Control and Prevention, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Centers for Disease Control and Prevention, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Centers for Disease Control and Prevention, Deals By Market, 2011 to YTD 2017 8
Centers for Disease Control and Prevention, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Centers for Disease Control and Prevention Enters into Research Agreement with Edico Genome 10
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 11
Bruker Enters Into Research Agreement With Special Bacteriology Reference Laboratory 12
Centers for Disease Control and Prevention, Key Competitors 13
Centers for Disease Control and Prevention, Key Employees 14
Centers for Disease Control and Prevention, Subsidiaries 15

★調査レポート[Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析] (コード:DATA8011492)販売に関する免責事項を必ずご確認ください。
★調査レポート[Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆